Cargando…
Multiplexed Serum Biomarkers for the Detection of Lung Cancer
Currently, there is no available biomarker for lung cancer diagnosis. Here we recruited 844 lung cancer patients and 620 healthy participants from six hospitals. A total of four serum proteins was identified and subsequently assessed in the training and validation cohorts. The concentrations of four...
Autores principales: | Ma, Shenglin, Wang, Wenzhe, Xia, Bing, Zhang, Shirong, Yuan, Haining, Jiang, Hong, Meng, Wen, Zheng, Xiaoliang, Wang, Xiaoju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049985/ https://www.ncbi.nlm.nih.gov/pubmed/27575387 http://dx.doi.org/10.1016/j.ebiom.2016.08.018 |
Ejemplares similares
-
Development of a Multiplex Autoantibody Test for Detection of Lung Cancer
por: Jia, Jing, et al.
Publicado: (2014) -
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
por: Li, Weili, et al.
Publicado: (2016) -
Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation
por: Zhang, Shirong, et al.
Publicado: (2015) -
Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum
por: Cai, Shenglin, et al.
Publicado: (2021) -
Increased MIR31HG lncRNA expression increases gefitinib resistance in non-small cell lung cancer cell lines through the EGFR/PI3K/AKT signaling pathway
por: Wang, Bing, et al.
Publicado: (2017)